Exploring the effects of a placebo probiotic on gut health and well-being
Official title: A 3-week Randomized Controlled Trial on the Efficacy of a Placebo Probiotic in Rebalancing Gut Health and Fostering Physical and Emotional Well-being in Individuals With Mild Gastrointestinal Symptoms
Run by Catholic University of the Sacred Heart · NCT06720558 · Data updated 2026-11-12
This study is testing if taking a fake probiotic that people think is real can help improve gut health and overall well-being in healthy individuals with mild stomach issues.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 65 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Catholic University of the Sacred Heart Academic / other |
| Locations | 1 site (Milan) |
| Status | Recruiting |
| Started | November 20, 2024 |
| Main results expected | April 2025 |
| Study ends | April 2025 |
| Registry record updated | December 6, 2024 |
| Trial ID | NCT06720558 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy individuals aged 20 to 65 with mild gastrointestinal symptoms that do not severely affect daily activities.
✕Probably not a fit
Patients with diagnosed functional gastrointestinal disorders or those suffering from neurodegenerative or psychiatric conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates whether positive expectations of receiving a probiotic supplement, which is actually a placebo, can improve gastrointestinal symptoms and enhance overall well-being in healthy individuals experiencing mild gastrointestinal distress. Participants will be divided into two groups: one receiving a deceptive placebo and another receiving no treatment initially. After a waiting period, the control group will be offered the placebo in an open-label manner, where they will be informed that the pills are inert. The study aims to compare the effects of the deceptive placebo against the open-label placebo and assess any significant improvements in symptoms and well-being.
Why it matters
Potential benefit: If successful, this study could provide insights into the psychological impact of placebos on gastrointestinal health and overall well-being.
How similar studies have gone: Previous studies have shown that placebos can have significant effects on health outcomes, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 20 and 65 * Individuals with mild gastrointestinal symptoms (e.g., digestive issues, acid reflux, constipation) such that normal every-day activities are not severly compromised. Exclusion Criteria: * Individuals with a diagnosis of functional gastrointestinal disorders (e.g., irritable bowel syndrome, ulcerative colitis, chronic inflammatory bowel diseases). * Individuals suffering from neurodegenerative diseases and/or psychiatric conditions * Individuals taking probiotic supplementation at the time of enrollment in the study
Where it's running
-
Catholic University of the Sacred Heart
Milan, Italy Recruiting
Study contacts
- Study coordinator: Diletta Barbiani
- Email: diletta.barbiani@unicatt.it
- Phone: +393338059338
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?
This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
-
Miricell supplementation and markers of healthy aging
This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.
-
Does daily lean beef support brain health in older adults
In healthy adults aged 65 and up, this study tests whether eating lean beef every day for two weeks can influence brain health markers compared with a non-beef, protein-matched option.
-
Adaptive computerized training to boost thinking in healthy seniors and those with mild cognitive impairment
This study tests whether a computer-based training program can improve executive thinking in older adults, including those with mild cognitive impairment, and see if it also helps memory and well-being.
-
SHARP: Personalized Health and Behavior Plan to Lower Biological Age in Older Adults
A 12-month randomized trial tests whether a personalized health and behavior program can lower biological age and improve function in healthy adults over 50.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.